Soterios Pharma Wraps Up Phase II Enrollment for STS-01 in Alopecia Areata
Soterios Pharma, a clinical-stage pharmaceutical company, has announced the completion of target enrollment for its Phase II trial with STS-01, a treatment for mild... Read more.
FDA Warns of Dangerous Lead Levels in WanaBana Apple Cinnamon Fruit Puree Pouches for Children
The U.S. Food and Drug Administration (FDA) has issued a warning about certain pureed fruit pouches from WanaBana, cautioning that they may contain dangerously high... Read more.
Biden Administration Urges Schools to Stock Naloxone, the Lifesaving Opioid Overdose Treatment
In a significant move, the Biden administration is encouraging schools across the United States to have naloxone readily available, a critical measure to prevent... Read more.
FDA Approves Wezlana as an Interchangeable Biosimilar to Stelara for Multiple Inflammatory Diseases
The U.S. Food and Drug Administration (FDA) has granted approval to Wezlana (ustekinumab-auub) as an interchangeable biosimilar to Stelara (ustekinumab) for the... Read more.
Paxlovid Shows Limited Efficacy in Reducing Most Post-COVID Conditions
A recent study has revealed that nirmatrelvir-ritonavir, a drug combination often used in the treatment of COVID-19, does not significantly reduce the incidence... Read more.
Study Highlights the Relationship Between Statin Use and Type 2 Diabetes
In a recent study, researchers have delved into the connection between statin use and the risk of developing Type 2 diabetes (T2D), shedding new light on the potential... Read more.
Careprost: Uses, Mechanism of Action, Dosage, Side Effects, and Where to Buy Authentic Careprost Online
In the world of pharmaceuticals, Careprost, also known as Bimatoprost Ophthalmic Solution, holds a unique position due to its dual-purpose application. Originally... Read more.
Hengrui Pharma Teams Up with Merck KGaA for Cancer Therapies
Jiangsu Hengrui Pharmaceuticals Co., Ltd (Hengrui Pharma), a globally recognized pharmaceutical company known for its commitment to scientific and technological... Read more.
Next-Generation Sequencing Market Set to Grow by USD 3.41 Billion from 2022 to 2027 at a CAGR of 12.45% – Technavio
According to a recent market study by Technavio, the Next-Generation Sequencing (NGS) market is anticipated to witness significant growth, with a forecasted increase... Read more.
EGFR Inhibitors Market to Surge by USD 6.75 Billion by 2028, Led by North America – Report
The global market for Epidermal Growth Factor Receptor (EGFR) inhibitors is projected to witness remarkable growth, surging by USD 6.75 billion from 2024 to 2028.... Read more.